Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bacterial Meningitis I: Introduction

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...

Bacterial Meningitis II: Pathophysiology

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Vaccinations

Vaccinations

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Viral Meningitis

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<b>A new species of the genus <i>Pristiceros</i> Gravenhorst, 1829 (Hymenoptera: Ichneumonidae) from Europe and Japan</b>.

Zootaxa·2026

Same author

Characterizing pediatric xylazine exposures reported to United States poison centers, 2010-2024.

Clinical toxicology (Philadelphia, Pa.)·2026

Same author

Opioid Use Disorder and Nonfatal Opioid-Involved Overdose Among Medicaid-Enrolled US Youth, 2020-2023.

JAMA pediatrics·2025

Same author

Opioid Dispensing Trends Among Children and Adolescents Aged ≤ 19 Years in the United States: 2018-2022.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2025

Same author

Prevention and Management of Opioid use Disorder and Overdose in Adolescents and Young Adults.

Current psychiatry reports·2025

Same author

Trends in Concurrent Opioid and Stimulant Dispensing to US Children and Adolescents: 2015-2024.

Pediatrics·2025

Search research articles

Related Experiment Video

Updated: May 27, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Meningococcal conjugate vaccines: optimizing global impact.

Andrew Terranella¹, Amanda Cohn, Thomas Clark

¹Epidemic Intelligence Service, Division of Applied Sciences, Scientific Education and Professional Development Program Office. aqt1@cdc.gov

Infection and Drug Resistance

|November 25, 2011

Summary

This summary is machine-generated.

Meningococcal conjugate vaccines offer superior protection compared to older types, leading to reduced disease globally. Long-term effectiveness and herd immunity require further study for optimal global vaccination strategies.

Keywords:

conjugate vaccine meningitis meningococcal disease meningococcal vaccine

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Experiment Videos

Last Updated: May 27, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Area of Science:

Vaccinology
Immunology
Epidemiology

Background:

Meningococcal conjugate vaccines (MCVs) offer advantages over polysaccharide vaccines, including enhanced antibody persistence, avidity, and immunologic memory.
Global MCV programs since 1999 have significantly reduced meningococcal disease incidence in numerous countries.
The introduction of serogroup A MCV in Africa presents an opportunity to eliminate meningococcal disease as a public health concern.

Purpose of the Study:

To evaluate the long-term effectiveness of meningococcal conjugate vaccines.
To assess the development of herd immunity following widespread vaccination.
To determine optimal vaccination strategies tailored to country-specific meningococcal disease epidemiology.

Main Methods:

Review of global meningococcal conjugate vaccine program data.
Analysis of disease incidence trends post-vaccination.
Epidemiological modeling to assess herd immunity and long-term immune response.

Main Results:

MCV programs have demonstrated significant reductions in meningococcal disease burden.
Questions remain regarding the duration of immune response and the extent of herd immunity achieved.
Country-specific epidemiological factors influence the success of vaccination strategies.

Conclusions:

Meningococcal conjugate vaccines are highly effective in reducing disease incidence.
Further research is needed to understand long-term immunity and optimize global vaccination strategies.
Tailoring vaccination approaches to local epidemiology is crucial for sustained disease prevention.